missing translation for 'onlineSavingsMsg'
Learn More

Leflunomide Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111019409
missing translation for 'changeView'
missing translation for 'orderingAttributeHoverText'
Quantity:
1 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
111019409 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 missing translation for 'options'
Catalog No. 111019409 missing translation for 'mfr' Merck Emd Millipore missing translation for 'supplierNo' PHR13781G
Only null left
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Leflunomide belongs to the new class of immunomodulating drugs with inflammatory and immunomodulating properties. It has been investigated for application in transplantation procedures. It is also an anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA). Its mode of action involves the inhibition of T-cell proliferation after converting to its active metabolite i.e. A771726 in humans.

Specifications

CAS 75706-12-6
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
Physical Form Neat
Linear Formula C12H9F3N2O2
MDL Number MFCD00867593
Synonym Leflunomide; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide
Type Certified Reference Material
Quantity 1 g
Formula Weight 270.21
Grade Certified Reference Material